San Francisco, 17 December 2018: The Report Primary Cell Culture Market Analysis Report By Product, By Application (Stem Cell
Therapy, Vaccine Production), By Separation and Culture Method, By Region, And
Segment Forecasts, 2018 - 2025
The global primary
cell culture market size is expected to reach USD 5.4 billion by 2025 and
is expected to register a CAGR 10.6% during the forecast period,according to a
new report by Grand View Research, Inc. Growth in production of vaccines,
monoclonal antibodies, and regenerative medicines, patent expiration of
blockbuster biologics, and rising demand for stem cell therapy and tissue
engineering are factors promoting the growth of this market. These trends are
attracting big players in healthcare and medical research toward this field.
 |
| Primary Cell Culture Market |
Primary cell culture is increasingly being
used in fields such as drug screening, organogenesis, disease diagnosis,
biological product manufacturing, cancer research, and stem cell research. Due
to their increased use in various healthcare domains, private medical
organizations, pharmaceutical and biotech companies, education, research and
government organizations have increased their investments and funding in this
market.
Primary cells show high physiological
resemblance to the tissues and organs they are extracted from. This provides
immense help to researchers and scientists in understanding various
complexities related to drug pathways, studying diseases and drug development,
and their effect on biological site of action in-vivo. Due to these qualities,
their use has increased in biopharmaceuticals, transplants, and chronic disease
therapies. Their sprouting customized use for different research purposes is
also a key trend in the industry.
However, there are many ethical concerns
over the usage of human embryonic cells, which poses as a major restraint in
the growth of this market. Usage of transgenic plants and animals and stem
cells, as well as stringent rules and regulations associated with it, will also
negatively affect market growth in the years to come.
Currently, North America holds the largest
share in the market, with Asia Pacific expected to witness the fastest growth
during the forecast period. This can be attributed to rising per capita
incomes, growing healthcare affordability, and improving economic status of
countries such as India and China.
Commercial players in this market are
mostly established companies; however, several new players have been making their
presence known in recent years. Some of the key players are Merck KGaA; Lonza;
Promocell GmbH; GE Healthcare; and Corning, Inc.
Access Research Report of Primary Cell Culture Market @ www.grandviewresearch.com/industry-analysis/primary-cell-culture-market
Further key findings from the report suggest:
· Growing need for stem cells transplants and
increasing number of clinical research studies and medical therapies for
chronic diseases are expected to drive the market
· Increasing prevalence of chronic illnesses
all over the world and ongoing researches in several therapeutic areas has
resulted in rapid advancements in stem cell therapy, cancer treatment, gene
therapy, and regenerative medicine
· While media held the dominant share by way
of product, the reagents and supplements segment is expected to register a CAGR
of 10.8% during the forecast period
· On the basis of separation and culture
technique, enzymatic disaggregation held the dominant share in 2017. This is
due to high productivity yield and less damage associated with this technique.
Enzymes widely used for carrying out degradation process include trypsin,
collagenase, and papain
· North America holds the largest revenue
share in the market. Registering a CAGR of 12.2% during the forecast period,
Asia Pacific is poised to emerge as the fastest growing region in the coming
years
· Lonza, Merck, Thermo Fisher, and GE
Healthineers are some of the leading players in this market. The number of new
players venturing in this space is increasing each year.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the
global primary cell culture market based on product, application, separation
and culture technique, and region:
Primary Cell Culture Product Outlook
(Revenue, USD Million, 2014 - 2025)
·
Primary Cell
·
Reagents and Supplements
·
Media
Primary Cell Culture Application Outlook (Revenue, USD
Million, 2014 - 2025)
·
Tissue Culture & Tissue Engineering
·
Vaccine Production
·
Gene Therapy and Regenerative Medicine
·
Toxicity Testing and Drug Screening
·
Cancer Research
·
Model System
·
Virology
·
Prenatal Diagnosis
·
Stem Cell Therapy
·
Others
Primary Cell Culture Separation and Culture
Techniques Outlook (Revenue, USD Million, 2014 - 2025)
·
Explant Method
·
Enzymatic Disaggregation
·
Mechanical Separation
·
Others
Primary Cell Culture Regional Outlook
(Revenue, USD Million, 2014 - 2025)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
Access Press Release of
Primary Cell Culture Market@ www.grandviewresearch.com/press-release/global-primary-cell-culture-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment